News

  • Section of human stomach showing immune cells infiltrating the tissue

    Inflammation and stomach cancer: the H. pylori connection

    Through a greater understanding of H. pylori infection, we are identifying molecular targets that can be used for better diagnosis, new therapies and preventative treatments, such as vaccines, against the diseases caused by this bacterium.…  Read more

  • Tayla Penny researching UCB stem cell treatment

    Grant to improve understanding of UCB stem cell treatment

    Dr Tayla Penny will receive a grant of more than $96,000 from the Cerebral Palsy Alliance to advance her work on improving understanding of umbilical cord blood (UCB) stem cell treatment for perinatal brain injury.…  Read more

  • Dr Ina Rudloff_Professor Marcel Nold_CEO of Norman Beischer Foundation Andrew Brookes and Professor Claudia Nold

    Beischer Foundation sticks its ‘NEC’ out

    Any new parent will tell you how overwhelming it can feel to suddenly be caring for a fragile new life. Now imagine that this life came into the world before it was ready – the fragility is magnified and with it the number of unknowns and things that can go wrong.…  Read more

  • Professor Peter Fuller and Associate Professor Jun Yang establish the Primary Aldosteronism Centre of Research Excellence (PACE),

    Setting a new PACE for hypertension

    The establishment of the Primary Aldosteronism Centre of Research Excellence (PACE), brings together world-class researchers to improve the diagnosis of primary aldosteronism (PA)…  Read more

  • The immunofluorescence image is one of the mouse Fallopian tube showing IFNe expression (in green)

    Ovarian cancer breakthrough: tiny protein, big impact

    Their latest research, published in the esteemed journal, Nature, showed that the innate immune system produces a powerful weapon against ovarian cancer – interferon epsilon (IFNe) – a weapon just waiting to be harnessed to deliver an effective immunotherapy treatment option.…  Read more

  • Associate Professor Simon Chu rare ovarian cancer GCT researcher

    The power of patient experience in rare ovarian cancer

    For Associate Professor Simon Chu, the problem leading Hudson Institute’s research into rare ovarian cancers was getting access to large quantities of real-world data, and the solution came from a surprising place: social media.…  Read more

  • Ron Firestein, Paul Daniel, Xin (Claire) Sun utilising the CCMA to solve childhood cancer

    Childhood cancer detectives embrace open-source AI solution

    The Childhood Cancer Model Atlas leverages AI and global collaboration to accelerate treatments for paediatric solid and CNS tumours.…  Read more

  • Professor Suzanne Miller with her PhD students Arya Jithoo, Beth Piscopo, Charmaine Rock and Tegan White

    Fostering future science leaders

    In 2023 Professor Suzanne Miller was awarded the Monash University, Medicine, Nursing and Health Sciences, Dean’s Award for Excellence – Postgraduate Research Supervision. …  Read more

  • Interaction between STAT3 and SLIRP blue dye shows the cell nucleus

    Defeating lung cancer

    Associate Professor Dan Gough and his team have developed sophisticated models of lung cancer which allow them to model disease progression and observe response to current treatments in patients.…  Read more

  • Mitochondria

    How cell death affects your health

    A/Prof Lawlor leads the Cell Death and Inflammatory Signalling Group that investigates the intricate links between cell death and inflammation and how these processes impact various inflammatory and infectious diseases. …  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected